Please login to the form below

Not currently logged in
Email:
Password:

DS Biopharma promotes Dr Markus Weissbach

He moves to chief operating officer at the Irish drug discovery firm

Dr Markus Weissbach has been appointed chief operating officer at Irish drug discovery and development company DS Biopharma.

He previously served as the Dublin-based firm's medical director, which he joined after a spell running his own consultancy.

Prior to that his 25years in the pharma, biotech and CRO industries saw him hold senior roles that included chief medical officer (Europe) at Novartis Vaccines and Diagnostics, president of Icon Clinical Research (Europe) and director of clinical research and development at Takeda R&D (Europe).

Commenting on his new appointed, DS Biopharma's executive chairman Dr John Climax said: “I am delighted to welcome Dr Markus Weissbach into his new role within the DS team and I look forward to working with him in advancing the DS portfolio.”

14th September 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics